VYGR
Voyager Therapeutics Inc
NASDAQ: VYGR · HEALTHCARE · BIOTECHNOLOGY
$3.73
+2.47% today
Updated 2026-04-30
Market cap
$224.69M
P/E ratio
—
P/S ratio
5.57x
EPS (TTM)
$-2.04
Dividend yield
—
52W range
$3 – $6
Volume
0.7M
Voyager Therapeutics Inc (VYGR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |